245. Using Probability of Community-Acquired Pneumonia to Tailor Antimicrobials Among Inpatients (UP-CAPTAIN): A Pragmatic Randomized Trial Evaluating the Impact of Guided Test Interpretation on Antibiotic Use among Patients with Suspected Community-Acquired Respiratory Infection
Jonathan Baghdadi, Anthony Harris, Lisa Pineles, Shatha AlShanqeeti, Danica Palacio, Drew W Charles, Emily L Heil, Kimberly C Claeys, J A C Q U E L I N E T BORK, Melinda M Neuhauser, Sarah Kabbani, Sarah Sommerkamp, R Gentry Wilkerson, Mark Sutherland, J Kristie Johnson

TL;DR
A study found that using a risk calculator to guide antibiotic decisions reduced unnecessary antibiotic use in hospitalized patients with respiratory infections.
Contribution
A new approach using guided test interpretation significantly reduced antibiotic use without harming patient outcomes.
Findings
Antibiotic use was reduced with the intervention (median 7.5 vs. 11 days of therapy).
More patients discontinued antibiotics within 5 days under the intervention (76% vs. 49%).
Clinical outcomes like length of stay and readmission were similar between groups.
Abstract
Respiratory illness is the most common reason for unnecessary antibiotic therapy in hospitalized adults. Although procalcitonin and respiratory virus testing help differentiate between viral and bacterial illness, they tend not to influence antibiotic decision-making.Figure 1.Testing Wisely Disease Risk Calculator for Bacterial PneumoniaFigure 2.Example of Templated Note for a Patient with Low Post-test Probability of Bacterial Pneumonia Testing Wisely Disease Risk Calculator for Bacterial Pneumonia Example of Templated Note for a Patient with Low Post-test Probability of Bacterial Pneumonia We conducted a pragmatic randomized-controlled trial comparing antimicrobial stewardship-guided test interpretation versus usual care among hospitalized adults receiving antibiotics for suspected respiratory infection with either low serum procalcitonin or positive respiratory virus testing at 2…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAntibiotic Use and Resistance · Sepsis Diagnosis and Treatment · Nosocomial Infections in ICU
